We are live on ! Find out more
LKFT

Lakefront Biotherapeutics American Depositary Shares

83 hedge funds and large institutions have $783M invested in Lakefront Biotherapeutics American Depositary Shares in 2025 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 22 increasing their positions, 30 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 15

2% more funds holding

Funds holding: 8183 (+2)

0.17% more ownership

Funds ownership: 47.16%47.33% (+0.17%)

9% less capital invested

Capital invested by funds: $857M → $783M (-$73.7M)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

26% less call options, than puts

Call options by funds: $6.42M | Put options by funds: $8.68M

27% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 30

Holders
83
Holders Change
+2
Holders Change %
+2.47%
% of All Funds
1.11%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
17
Increased
22
Reduced
30
Closed
15
Calls
$6.42M
Puts
$8.68M
Net Calls
-$2.27M
Net Calls Change
-$25.8M
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
26
Millennium Management
New York
$1.58M +$525K +20,789 +49%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$1.58M +$1.59M +63,020 New
Bank of America
28
Bank of America
North Carolina
$1.5M +$939K +37,152 +165%
TC
29
Tejara Capital
United Kingdom
$1.35M +$1.36M +53,786 New
CGH
30
Crossmark Global Holdings
Texas
$1.24M +$4.27K +169 +0.3%
Two Sigma Investments
31
Two Sigma Investments
New York
$1.23M +$1.24M +49,161 New
AA
32
ALPS Advisors
Colorado
$1.21M -$131K -5,169 -10%
Two Sigma Advisers
33
Two Sigma Advisers
New York
$1.09M +$1.1M +43,500 New
CC
34
Centiva Capital
New York
$968K +$974K +38,551 New
SCM
35
Suvretta Capital Management
New York
$932K
MAM
36
Monaco Asset Management
Monaco
$905K +$532K +21,036 +140%
Barclays
37
Barclays
United Kingdom
$800K +$784K +31,029 +3,734%
Optiver Holding
38
Optiver Holding
Netherlands
$764K +$768K +30,408 New
Verition Fund Management
39
Verition Fund Management
Connecticut
$755K +$313K +12,386 +70%
Citigroup
40
Citigroup
New York
$746K -$3.97K -157 -0.5%
American Century Companies
41
American Century Companies
Missouri
$699K +$50.2K +1,987 +8%
MNBTD
42
Moody National Bank Trust Division
Texas
$657K
Morgan Stanley
43
Morgan Stanley
New York
$638K -$3M -118,730 -82%
ACM
44
Aquatic Capital Management
Illinois
$604K -$60.5K -2,393 -9%
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$576K +$579K +22,912 New
PCM
46
Prelude Capital Management
New York
$485K +$4.3K +170 +0.9%
EAM
47
Erste Asset Management
Austria
$356K
BCM
48
Barometer Capital Management
Ontario, Canada
$340K +$104K +4,100 +44%
AA
49
ABC Arbitrage
France
$333K +$335K +13,241 New
Commonwealth Equity Services
50
Commonwealth Equity Services
Massachusetts
$285K +$287K +11,360 New

LKFT Hedge Fund Activity: Q1 2025 in Review

83 of the 7,461 institutional investors tracked by Wall St. Rank reported a position in Lakefront Biotherapeutics American Depositary Shares (LKFT) for Q1 2025, worth a combined $783M — down 8.6% from $857M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new LKFT positions and 15 closed out — a net gain of 2 holders — while 22 added to existing stakes and 30 trimmed.

The largest buyer was Tang Capital Management, adding an estimated $45.5M. The largest seller was Deerfield Management, exiting entirely with an estimated $38.8M sold.

  • 83 institutional investors held Lakefront Biotherapeutics American Depositary Shares (LKFT) as of Q1 2025, up from 81 in Q4 2024.
  • Funds reported $783M of Lakefront Biotherapeutics American Depositary Shares stock for Q1 2025, down 8.6% quarter-over-quarter.
  • 17 funds opened new Lakefront Biotherapeutics American Depositary Shares positions in Q1 2025 and 15 closed out, a net change of +2 holders.
  • The largest Lakefront Biotherapeutics American Depositary Shares buyer in Q1 2025 was Tang Capital Management, an estimated $45.5M added.
  • The largest Lakefront Biotherapeutics American Depositary Shares seller in Q1 2025 was Deerfield Management, an estimated $38.8M sold.

Based on aggregated 13F filings for Q1 2025.